FDA Investigator Gregory R Dill
Gregory R Dill has inspections in 1 countries as of 18 Aug 2023. Gregory R Dill has collaborated with a combined 1670 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
18 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Ana L Kewes,
Andrew A Leboeuf,
Anthony F Lorenzo,
Anthony R Ronga,
Barbara G Langer,
Brian D Nicholson,
Brittani N Franklin,
Bruce H Mccullough,
Bryan L Mcguckin,
Burnell M Henry,
Carrie Ann Plucinski,
CDR Sean T Creighton,
Chad E Schmear,
Chase S Baldwin,
Christina A Miller,
Christopher D Leach,
Dariusz Galezowski,
Darrell E Luedtke,
David J Gasparovich,
David Perkins,
Debra Boyd Seale,
Debra I Love,
Debra L Boyd Seale,
Denarvis C Mendenhall,
Denise L Burosh,
Dr. Gang Wang, PhD,
Emilie E Kahn,
Eric M Mueller, PharmD,
Eric S Pittman,
Eric S Rittman,
Jacqueline Mdiaz Albertini,
James E Roberts,
James L Finn,
James W Plucinski,
Janae D Price,
Jason F Chancey,
Jeanne M Morris,
Jennifer J Edmiston,
Jennifer L Mecher,
Jerri E Lothrop,
Jesse A Vazquez,
Joan A Loreng,
Jocelyn C Turner,
John M Seale,
Joseph D Cooper,
Joshua M Adams,
Karen Emasley Joseph,
Kyran R Gibson,
Lawrence J Stringer,
LCDR Mark A Jimenez, RN,
Leeterry Moore,
Lequita M Mayhew,
Lisa C Lewis,
Lisa Hayka,
Lorelei S Jarrell,
Maksim A Levenchuk,
Marcia A Worley,
Margaret Torres Vazquez,
Mark E Frank,
Mark I Kaspar,
Matthew J Sienko,
Michael E Maselli,
Michele L Glendenning,
Min Chu Chen,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole J Clausen,
Nicole S Williams,
Norman Wong,
Pablo Alcantara,
Paola S Barnett,
Patricia A Mcilroy,
Patrick E Gainer,
Peterson,
Phung Thien Nguyen,
Prabhu P Raju,
Rachel T Evans,
Roberta W Cunningham,
Rose M Ashley,
Rosemary A Sexton,
Russell K Riley,
Ruth Smith,
Simone E Pitts,
State Agency,
Stefen D Mcmillan,
Stephen D Eich,
Sullan,
Susan P Bruederle,
Susan W Ciani,
Tamara Brey,
That Q Dang,
Todd M Stankewicz,
Vioela J Caze,
William R Weissinger,
Yuriy Solovyov
Gregory R Dill's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2004 | EIR | Baxter Healthcare Corporation - EIR, 2004-11-17 |
July, 2004 | EIR | BASF Corporation - EIR, 2004-07-02 |
November, 2004 | FDA 483 | Baxter Healthcare Corporation - Form 483, 2004-11-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more